Cargando…
Letrozole cotreatment improves the follicular output rate in high-body-mass-index women with polycystic ovary syndrome undergoing IVF treatment
BACKGROUND: Women who have polycystic ovary syndrome (PCOS) with high body mass index (BMI) typically have an attenuated ovarian response and decreased follicular size, which are linked to unfavourable clinical outcomes following in vitro fertilization (IVF) therapy. The follicular output rate (FORT...
Autores principales: | Liu, Yali, Lin, Jiaying, Shen, Xi, Zhu, Qianqian, Kuang, Yanping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020617/ https://www.ncbi.nlm.nih.gov/pubmed/36936138 http://dx.doi.org/10.3389/fendo.2023.1072170 |
Ejemplares similares
-
Letrozole cotreatment with progestin-primed ovarian stimulation in women with polycystic ovary syndrome undergoing IVF treatment
por: Liu, Yali, et al.
Publicado: (2022) -
Effect of different timing of letrozole initiation on pregnancy outcome in polycystic ovary syndrome
por: Shi, Lan, et al.
Publicado: (2022) -
Impact of 2.5 mg versus 5 mg letrozole co-treatment in an antagonist protocol for IVF: a retrospective study
por: Lin, Jing, et al.
Publicado: (2023) -
Factors Associated with Ovarian Hyperstimulation Syndrome (OHSS) Severity in Women With Polycystic Ovary Syndrome Undergoing IVF/ICSI
por: Sun, Bo, et al.
Publicado: (2021) -
The pregnancy outcomes of infertile women with polycystic ovary syndrome undergoing intrauterine insemination with different attempts of previous ovulation induction
por: Gao, Yining, et al.
Publicado: (2022)